@article{c89e09dc2f964a29b3a94430057c1310,
title = "Should we be using intraarticular tumor necrosis factor blockade in inflammatory monoarthritis?",
keywords = "Adalimumab, Antibodies, Monoclonal/administration & dosage, Antibodies, Monoclonal, Humanized, Antirheumatic Agents/administration & dosage, Arthritis/drug therapy, Dose-Response Relationship, Drug, Etanercept, Humans, Immunoglobulin G/administration & dosage, Infliximab, Injections, Intra-Articular, Receptors, Tumor Necrosis Factor/administration & dosage, Tumor Necrosis Factor-alpha/antagonists & inhibitors",
author = "Fisher, {Benjamin A C} and Andrew Keat",
year = "2006",
month = oct,
language = "English",
volume = "33",
pages = "1934--5",
journal = "The Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "10",
}